Stock Analiz

RxSight, Inc. (RXST) stock forecast and price target

Price $5.32 · data as of November 13, 2026

12-month price target

Average target$6.10
Upside / downside+14.7%
Analysts8
ConsensusHold
Low $5.00Average $6.10High $8.00

Gold marker: average target · white marker: today’s price ($5.32)

Analyst ratings

Strong buy 1Buy 0Hold 7Sell 0Strong sell 2

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.13+29.6%$147M
Next fiscal year
ends December 31, 2027
$-0.67−432.7%$116M
Next quarter
ends December 31, 2026
$0.33+1215.4%$58M
Quarter after
ends March 31, 2027
$-0.14+28.9%$30M

Consensus of the analysts covering RxSight, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Our model vs. Wall Street

Analysts see 14.7% upside over 12 months. Our discounted cash flow model with moderate assumptions puts RxSight’s intrinsic value about 79% below today’s market value, and it scores 1.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the RxSight stock price target?

The average 12-month target from 8 analysts is $6.10, 14.7% above the current price of $5.32 Targets range from $5.00 to $8.00.

Is RxSight a buy according to analysts?

The consensus rating is “Hold” (1 strong buy, 7 hold, 2 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is RxSight expected to earn?

Analysts expect EPS of $-0.13 for the fiscal year ending December 31, 2026 and $-0.67 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.